Skip to content

Author

P. Iruzubieta

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease.

Importance Although metabolic dysfunction-associated steatotic liver disease (MASLD) is traditionally associated with obesity, it is increasingly recognized in individuals with normal weight (ie, lean MASLD). Objective To characterize the clinical, histologic, and prognostic features of lean MASLD, and evaluate the p...

L. de Avila, K. Al-Naamani, M. Papatheodoridi et al. · 1 citation
Sep 2026

Reading the glycome in MASLD: at the crossroads of metabolism and inflammation.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as the hepatic expression of a broader cardiometabolic and inflammatory disorder. In this context, circulating glycoprotein signals may provide information beyond conventional assessment of steatosis and fibrosis risk. García-Ma...

Javier Crespo, P. Iruzubieta · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.